Actionable news
All posts from Actionable news
Actionable news in GILD: Gilead Sciences, Inc.,

Gilead's hep B drug succeeds in late-stage trials

Jan 5 (Reuters) - Gilead Sciences Inc said its once-daily experimental hepatitis B drug was found to be as effective as its approved drug, Viread, in two late-stage studies.

The drug, tenofovir...